{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Naviglio S, Lacorte D, Lucaf\'f2 M, Cif\'f9 A, Favretto D, Cuzzoni E, Silvestri T, Mucelli MPozzi, Radillo O, Decorti G, Fabris M, Bramuzzo M, Taddio A, Stocco G, Alvisi P, Ventura A, Martelossi S. Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study. J Pediatr Gastroenterol Nutr 2019;68(1):37-44.\par \par Benelli E, Naviglio S, De Leo L, Stera G, Giangreco M, Ronfani L, Villanacci V, Martelossi S, Ventura A, Not T. Changing Epidemiology of Liver Involvement in Children With Celiac Disease. J Pediatr Gastroenterol Nutr 2019;68(4):547-551.\par \par De Leo L, Aeschlimann D, Hadjivassiliou M, Aeschlimann P, Salce N, Vatta S, Ziberna F, Cozzi G, Martelossi S, Ventura A, Not T. Anti-transglutaminase 6 Antibody Development in Children With Celiac Disease Correlates With Duration of Gluten Exposure. J Pediatr Gastroenterol Nutr 2018;66(1):64-68.\par \par Girardelli M, Basaldella F, Paolera SDella, Vuch J, Tommasini A, Martelossi S, Crovella S, Bianco AMonica. Genetic profile of patients with early onset inflammatory bowel disease. Gene 2018;645:18-29.\par \par De Iudicibus S, Lucaf\'f2 M, Vitulo N, Martelossi S, Zimbello R, De Pascale F, Forcato C, Naviglio S, Di Silvestre A, Gerdol M, Stocco G, Valle G, Ventura A, Bramuzzo M, Decorti G. High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients. Int J Mol Sci 2018;19(5)\par \par De Leo L, Villanacci V, Ziberna F, Vatta S, Martelossi S, Di Leo G, Zanchi C, Bramuzzo M, Giudici F, Ventura A, Not T. Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children. Gastrointest Endosc 2018;88(3):521-526.\par \par Matarazzo L, Assandro P, Martelossi S, Maggiore G, Ventura A. Multiple successful pregnancies in a woman with biliary atresia and native liver. Eur J Obstet Gynecol Reprod Biol 2018;221:194-195.\par \par Ottaviano G, Salvatore S, Salvatoni A, Martelossi S, Ventura A, Naviglio S. Ocular Manifestations of Paediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis 2018;12(7):870-879.\par \par Lucaf\'f2 M, Di Silvestre A, Romano M, Avian A, Antonelli R, Martelossi S, Naviglio S, Tommasini A, Stocco G, Ventura A, Decorti G, De Iudicibus S. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease. Basic Clin Pharmacol Toxicol 2018;122(1):87-93.\par \par Stocco G, Martelossi S, Arrigo S, Barabino A, Aloi M, Martinelli M, Miele E, Knafelz D, Romano C, Naviglio S, Favretto D, Cuzzoni E, Franca R, Decorti G, Ventura A. Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23(4):628-634.\par \par Naviglio S, Parentin F, Nider S, Rassu N, Martelossi S, Ventura A. Ocular Involvement in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23(6):986-990.\par \par Lucaf\'f2 M, Bravin V, Tommasini A, Martelossi S, Rabach I, Ventura A, Decorti G, De Iudicibus S. Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance. Clin Exp Pharmacol Physiol 2016;43(6):602-5.\par \par Aloi M, D?Arcangelo G, Bramuzzo M, Gasparetto M, Martinelli M, Alvisi P, Illiceto MTeresa, Valenti S, Distante M, Pellegrino S, Gatti S, Arrigo S, Civitelli F, Martelossi S. Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis. Inflamm Bowel Dis 2016;22(7):1647-54.\par \par Radillo O, Pascolo L, Martelossi S, Dal Bo S, Ventura A. Fecal Calprotectin: Diagnostic Accuracy of the Immunochromatographic CalFast Assay in a Pediatric Population. J Clin Lab Anal 2016;\par \par Ziberna F, De Lorenzo G, Schiavon V, Arnoldi F, Quaglia S, De Leo L, Vatta S, Martelossi S, Burrone OR, Ventura A, Not T. Lack of Evidence of Rotavirus-Dependent Molecular Mimicry as a Trigger of Celiac Disease. Clin Exp Immunol 2016;\par \par Bramuzzo M, Ventura A, Martelossi S, Lazzerini M. Thalidomide for inflammatory bowel disease: Systematic review. Medicine (Baltimore) 2016;95(30):e4239.\par \par Pelin M, De Iudicibus S, Londero M, Spizzo R, Rossi SDei, Martelossi S, Ventura A, Decorti G, Stocco G. Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress. Curr Drug Metab 2016;17(6):542-9.\par \par Benelli E, Carrato V, Martelossi S, Ronfani L, Not T, Ventura A. Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study. Arch Dis Child 2015;\par \par Lazzerini M, Martelossi S, Magazz\'f9 G, Pellegrino S, Lucanto MCristina, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MChiara, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A. Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial. Inflamm Bowel Dis 2015;21(8):1739-49.\par \par Lazzerini M, Martelossi S, Cont G, Bersanini C, Ventura G, Fontana M, Zuin G, Ventura A, Taddio A. Orofacial granulomatosis in children: think about Crohn's disease. Dig Liver Dis 2015;47(4):338-41.\par \par Stocco G, Lanzi G, Yue F, Giliani S, Sasaki K, Tommasini A, Pelin M, Martelossi S, Ventura A, Decorti G. Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?. Curr Drug Metab 2015;17(1):91-8.\par \par Lazzerini M, Martelossi S, Ventura A. Reply to Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug. Inflamm Bowel Dis 2015;21(8):1752-3.\par \par Pelin M, De Iudicibus S, Fusco L, Taboga E, Pellizzari G, Lagatolla C, Martelossi S, Ventura A, Decorti G, Stocco G. Role of oxidative stress mediated by glutathione-s-transferase in thiopurines' toxic effects. Chem Res Toxicol 2015;28(6):1186-95.\par \par De Leo L, Quaglia S, Ziberna F, Vatta S, Martelossi S, Maschio M, Not T. Serum anti-tissue transglutaminase antibodies detected during febrile illness may not be produced by the intestinal mucosa. J Pediatr 2015;166(3):761-3.\par \par Pederiva F, Daniela C, Scarpa M-G, Guida E, Dragovic D, Martelossi S. An asymptomatic multiple magnet ingestion with transmesenteric entero-enteric fistula. APSP J Case Rep 2014;5(2):16.\par \par Quaglia S, De Leo L, Ziberna F, Vatta S, Villanacci V, Granzotto M, Petix V, Martelossi S, Di Leo G, Torelli L, Not T. Intestinal-mucosa anti-transglutaminase antibody assays to test for genetic gluten intolerance. Cell Mol Immunol 2014;11(6):617-20.\par \par Bramuzzo M, Martelossi S, Villanacci V, Maschio M, Costa S, Ventura A. Multiple Ileo-Ileal Intussusceptions Caused by Eosinophilic Enteropathy. J Pediatr Gastroenterol Nutr 2014;\par \par Stocco G, Pelin M, Franca R, De Iudicibus S, Cuzzoni E, Favretto D, Martelossi S, Ventura A, Decorti G. Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?. World J Gastroenterol 2014;20(13):3534-41.\par \par Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, Fabretto A, Vignola S, Lonardi S, Ventura A. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis 2014;8(8):770-4.\par \par Lazzerini M, Martelossi S, Ventura A. Use of placebo in a trial of thalidomide for pediatric Crohn disease--reply. JAMA 2014;311(12):1251-2.\par \par Lazzerini M, Bramuzzo M, Martelossi S, Magazz\'f9 G, Pellegrino S, Ventura A. Amenorrhea in women treated with thalidomide: report of two cases and literature review. Inflamm Bowel Dis 2013;19(1):E10-1.\par \par Bianco AMonica, Zanin V, Monasta L, Martelossi S, Marcuzzi A, Crovella S. Family history in early-onset inflammatory bowel disease. J Gastroenterol 2013;48(1):144.\par \par Minen F, De Cunto A, Martelossi S, Ventura A. Acute and recurrent pancreatitis in children: exploring etiological factors. Scand J Gastroenterol 2012;47(12):1501-4.\par \par Bianco AMonica, Zanin V, Girardelli M, Magnolato A, Martelossi S, Martellossi S, Tommasini A, Marcuzzi A, Crovella S. A common genetic background could explain early-onset Crohn's disease. Med Hypotheses 2012;78(4):520-2.\par \par Minen F, Cont G, De Cunto A, Martelossi S, Ventura A, Maggiore G, Faletra F, Gasparini P, Cassandrini D. Delayed diagnosis of glycogen storage disease type III. J Pediatr Gastroenterol Nutr 2012;54(1):122-4.\par \par Marcuzzi A, Girardelli M, Bianco AMonica, Martelossi S, Magnolato A, Tommasini A, Crovella S. Inflammation profile of four early onset Crohn patients. Gene 2012;493(2):282-5.\par \par Comar M, Secchiero P, De Lorenzo E, Martelossi S, Tommasini A, Zauli G. JCV+ Patients with Inflammatory bowel disease show elevated plasma levels of MIG and SCF. Inflamm Bowel Dis 2012;18(6):1194-6.\par \par Bellini A, Zanchi C, Martelossi S, Di Leo G, Not T, Ventura A. Compliance with the gluten-free diet: the role of locus of control in celiac disease. J Pediatr 2011;158(3):463-466.e5.\par \par Not T, Ziberna F, Vatta S, Quaglia S, Martelossi S, Villanacci V, Marzari R, Florian F, Vecchiet M, Sulic A-M, Ferrara F, Bradbury A, Sblattero D, Ventura A. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Gut 2011;60(11):1487-93.\par \par De Iudicibus S, Stocco G, Martelossi S, Londero M, Ebner E, Pontillo A, Lionetti P, Barabino A, Bartoli F, Ventura A, Decorti G. Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases. J Clin Gastroenterol 2011;45(1):e1-7.\par \par De Iudicibus S, Franca R, Martelossi S, Ventura A, Decorti G. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 2011;17(9):1095-108.\par \par Lazzerini M, Bramuzzo M, Maschio M, Martelossi S, Ventura A. Thromboembolism in pediatric inflammatory bowel disease: systematic review. Inflamm Bowel Dis 2011;17(10):2174-83.\par \par Taddio A, Simonini G, Lionetti P, Lepore L, Martelossi S, Ventura A, Cimaz R. Usefulness of wireless capsule endoscopy for detecting inflammatory bowel disease in children presenting with arthropathy. Eur J Pediatr 2011;170(10):1343-7.\par \par Tommasini A, Pirrone A, Palla G, Taddio A, Martelossi S, Crovella S, Ventura A. The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease?. Scand J Gastroenterol 2010;45(10):1141-9.\par \par Stocco G, Londero M, Campanozzi A, Martelossi S, Marino S, Malus\'e0 N, Bartoli F, Decorti G, Ventura A. Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence. J Crohns Colitis 2010;4(5):599-602.\par \par }